4//SEC Filing
ORTH ANDREW C. 4
Accession 0001860010-22-000002
CIK 0001711279other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:22 PM ET
Size
5.8 KB
Accession
0001860010-22-000002
Insider Transaction Report
Form 4
ORTH ANDREW C.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+50,000→ 50,000 totalExercise: $63.55Exp: 2032-02-28→ Common Stock (50,000 underlying)
Holdings
- 100
Common Stock
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 28, 2023.
Documents
Issuer
Krystal Biotech, Inc.
CIK 0001711279
Entity typeother
Related Parties
1- filerCIK 0001860010
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 9:22 PM ET
- Size
- 5.8 KB